Follow-up after treatment of squamous cell carcinoma of the oral cavity: Current maxillofacial practice in the United Kingdom

Kerawala, Cyrus; Newlands, Carrie; Coombes, Darryl

doi:10.1016/j.bjoms.2006.09.018

Cited by 8 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As previously identified [ 47 ], HNC follow-up regimens appeared largely consistent between centres, with some local adaptations (as recommended [ 3 ]). Some elements of PIFU mentioned have been piloted in HNC – patient education interventions [ 34 ] and holistic appointments [ 48 ].…”

Section: Discussionmentioning

confidence: 64%

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

et al. 2022

View full text Add to dashboard Cite

Aims: Current follow-up for head and neck cancer (HNC) is ineffective, expensive and fails to address patients' needs. The PETNECK2 trial will compare a new model of patient-initiated follow-up (PIFU) with routine scheduled follow-up. This article reports UK clinicians' views about HNC follow-up and PIFU, to inform the trial design. Materials and methods: Online focus groups with surgeons (ear, nose and throat/maxillofacial), oncologists, clinical nurse specialists and allied health professionals. Clinicians were recruited from professional bodies, mailing lists and personal contacts. Focus groups explored views on current follow-up and acceptability of the proposed PIFU intervention and randomised controlled trial design (presented by the study co-chief investigator), preferences, margins of equipoise, potential organisational barriers and thoughts about the content and format of PIFU. Data were interpreted using inductive thematic analysis. Results: Eight focus groups with 34 clinicians were conducted. Clinicians highlighted already known limitations with HNC follow-up e lack of flexibility to address the wide-ranging needs of HNC patients, expense and lack of evidence e and agreed that follow-up needs to change. They were enthusiastic about the PETNECK2 trial to develop and evaluate PIFU but had concerns that PIFU may not suit disengaged patients and may aggravate patient anxiety/fear of recurrence and delay detection of recurrence. Anticipated issues with implementation included ensuring a reliable route back to clinic and workload burden on nurses and allied health professionals. Conclusions: Clinicians supported the evaluation of PIFU but voiced concerns about barriers to help-seeking. An emphasis on patient engagement, psychosocial issues, symptom reporting and reliable, quick routes back to clinic will be important. Certain patient groups may be less suited to PIFU, which will be evaluated in the trial. Early, meaningful, ongoing engagement with clinical teams and managers around the trial rationale and recruitment process will be important to discourage selective recruitment and address risk-averse behaviour and potential workload burden.

show abstract

Section: Discussionmentioning

confidence: 64%

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

et al. 2022

View full text Add to dashboard Cite

show abstract

“…37,38 Indeed, much of the literature published on this area focuses on specialist medical follow-up aimed primarily at the detection of recurrences or spread of disease. 10,35,39 In contrast, the focus of allied health and nursing professionals in the follow-up period is on quality of life and symptom management. 38 However, these services are usually booked on an ad-hoc basis, 37,38 which puts the onus on medical staff to identify the need for and refer to these services or patients to self-advocate for assistance.…”

Section: Discussionmentioning

confidence: 99%

“…While the inclusion of allied health and clinical nurse specialists is standard practice in most multidisciplinary HNC teams, how these services should be coordinated is poorly reflected in many post‐treatment protocols 37,38 . Indeed, much of the literature published on this area focuses on specialist medical follow‐up aimed primarily at the detection of recurrences or spread of disease 10,35,39 . In contrast, the focus of allied health and nursing professionals in the follow‐up period is on quality of life and symptom management 38 .…”

Section: Discussionmentioning

confidence: 99%

Post‐acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality

et al. 2022

View full text Add to dashboard Cite

Background: People with head and neck cancer (HNC) have complex health care needs; however, limited evidence exists regarding the nature or patterns of service access and use. This study explored the post-discharge health care needs and experiences of individuals with HNC from metropolitan and rural areas. Methods: Health care appointments and services accessed by people with HNC were collated for 6-month post-treatment. Data analysis of the whole cohort examined patterns of access while journey mapping integrated participants' experiences of recovery.Results: The 6-month service access journey was mapped for 11 people. Rural participants attended a significantly greater number of appointments (p = 0.012), higher canceled/missed appointments (p = 0.013), and saw more professionals (p = 0.007). Rural participants reported higher stress and burden due to service access barriers and unmet needs.

show abstract

“…The metastases of lung, bone, brain, liver, and skin permeation were diagnosed within approximately one year. In one study, due to the high risk of recurrence, distant metastasis, and second primary tumor, it is emphasized that patients should be followed for at least five years (24).…”

Section: Discussionmentioning

confidence: 99%

The Effect of Correlation Between Prognostic Factors and Long-Term Mortality in Tongue Cancers

Kubat¹,

Beton²,

Gerçeker³

2016

Istanbul Med J

View full text Add to dashboard Cite

The incidence of head and neck cancer is increasing in many parts of the world. Oral cavity cancer comprises approximately 3% of all types of cancer, and tongue cancer is the most common type of oral cavity cancer (1). Because a reliable epidemiological study has not yet been conducted, it is not possible to give a clear description of this subject in our country. Although head and neck cancer is usually diagnosed in the sixth decade of the patient's life, the prevalence among young patients (younger than 40 years) is increasing (2). Tongue cancer is more common in men; however, due to an increase in tobacco use, some studies have reported that the incidence of tongue cancer has increased among women as well.90% of the etiological factors of tongue cancer are associated with cigarettes, cigars, pipes, tobacco use, passive smoking, and alcohol consumption. Human papilloma virus (HPV) is also an infectious agent whose carcinogenic effects have been well proven (3). Other etiological factors are suppression of the immune system due to human immunodeficiency virus (HIV), long-term trauma secondary to the long-term use of inappropriate dentures, and poor oral hygiene.Squamous cell carcinoma (SCC) represents over 90% of oral cavity and tongue cancer cases (4). Premalignant lesions are classified as leukoplakia, erythroplakia, oral submucosal fibrosis, and oral lichen planus; studies conducted on this subject state that 6.6%-36.4% of premalignant lesions progress to invasive carcinoma within 1.5-8.5 years. Compared to leukoplakia, erythroplakia has a higher risk of malignancy (5).The tumor stage, histopathologic stage, growth pattern, lymph nodes in the neck and distant metastasis, and classification of the tumor as secondary or primary are important factors in determining the prognosis and survival in neck cancer cases. In cases of squamous cell carcinoma of the tongue, lymph node metastasis in the neck is quite common, and patients clinically diagnosed with non-metastatic lymph nodes in the neck (N0) have a high rate of occult metastasis.After histopathological diagnosis, for staging, computed tomography (CT) and/or magnetic resonance imaging (MRI) should be performed. Positron emission tomography (PET) is used in the determination of distant metastases in advanced stage disease (6).The choice of treatment varies depending on the status of the primary tumor and locoregional lymph node involvement. Surgery and radiotherapy (RT) can be applied as primary treatments The Effect of Correlation Between Prognostic Factors and Long-Term Mortality in Tongue CancersObjective: The aim of this study was to review demographic data, prognostic factors, and the effect on mortality of patients who were treated for tongue cancer and followed up at our clinic.Methods: Data between 2000 and 2013 were retrospectively reviewed. This report includes data from 96 patients. Demographic data, dental prostheses, smoking and drinking habits, CVs, tumor characteristics, treatment methods, recurrence, distant metastasis, second primary tumor pre...

show abstract

Follow-up after treatment of squamous cell carcinoma of the oral cavity: Current maxillofacial practice in the United Kingdom

Cited by 8 publications

References 22 publications

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

Post‐acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality

The Effect of Correlation Between Prognostic Factors and Long-Term Mortality in Tongue Cancers

Contact Info

Product

Resources

About